1. Home
  2. VSME vs MBIO Comparison

VSME vs MBIO Comparison

Compare VSME & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

N/A

Current Price

$0.92

Market Cap

5.0M

Sector

N/A

ML Signal

N/A

MBIO

Mustang Bio Inc.

N/A

Current Price

$0.47

Market Cap

4.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VSME
MBIO
Founded
2013
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.1M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
VSME
MBIO
Price
$0.92
$0.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.2M
25.8K
Earning Date
04-30-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.99
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$405.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.47
52 Week High
$5.38
$1.84

Technical Indicators

Market Signals
Indicator
VSME
MBIO
Relative Strength Index (RSI) 45.23 34.45
Support Level $0.77 $0.47
Resistance Level $1.00 $0.56
Average True Range (ATR) 0.10 0.03
MACD 0.01 -0.00
Stochastic Oscillator 18.85 10.21

Price Performance

Historical Comparison
VSME
MBIO

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: marketing services and social commerce. The firm generates almost all of its revenue from marketing services, which reflects the company's business of marketing services to clients and social media platforms. The social commerce segment reflects the company's business of social commerce with customers. Geographically, the firm generates revenue from the HK SAR and Taiwan.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: